Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Board and Management
Corporate Governance
Operations
Operations Overview
Mernova
Health House International
Creso Pharma Switzerland
Investors
Investors Home
ASX Announcements
Prospectus
Presentations
Annual Reports
Financial Reports
Share Price
Shareholder Services
Media
Right to Receive Documents
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
Media
Investors Home
ASX Announcements
Prospectus
Presentations
Annual Reports
Financial Reports
Share Price
Shareholder Services
Media
Right to Receive Documents
Media
9-Jun-2023
Creso Pharma and Apotheke Dr. Hysek partner to import MDMA and psilocybin treatments to Australia
5-Jun-2023
Creso Pharma trains sights on lucrative Australian market following change in licensing process
22-May-2023
Creso Pharma reports strong sales, licence extensions for Canadian subsidiary Mernova
19-May-2023
Creso Pharma raises A$2.5 million, streamlines balance sheet for growth strategy
17-May-2023
Creso Pharma strengthens market position on completing Health House International acquisition
15-May-2023
Creso Pharma hones in on pivotal Asian markets with Singapore and South Korea distribution deals
10-May-2023
Creso Pharma has eyes on multi-million dollar functional mushroom product market
8-May-2023
Creso Pharma gains Supreme Court green light for Health House acquisition
5-May-2023
Creso Pharma's subsidiary Halucenex demonstrates potential of psilocybin to treat PTSD
1-May-2023
Creso Pharma subsidiary secures new purchase orders and expands into Alberta
Click here for archives
